Current Medicinal Chemistry
Title:Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications
Volume: 26 Issue: 34
Author(s): Patrizia Ferroni and Piero Barbanti
Affiliation:
Export Options
About this article
Cite this article as:
Ferroni Patrizia and Barbanti Piero , Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications, Current Medicinal Chemistry 2019; 26 (34) . https://dx.doi.org/10.2174/092986732634191112142448
DOI https://dx.doi.org/10.2174/092986732634191112142448 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
24
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Current Neuropharmacology Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease?
Current Diabetes Reviews Telomeric G-Quadruplex Architecture and Interactions with Potential Drugs
Current Pharmaceutical Design Current Therapy and Computational Drug Designing Approaches for Neurodegenerative Diseases -with Focus on Alzheimer’s and Parkinson’s.
Current Signal Transduction Therapy An Update on GABA Analogs for CNS Drug Discovery
Recent Patents on CNS Drug Discovery (Discontinued) Solid-State NMR as a Probe of Amyloid Structure
Protein & Peptide Letters Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017
CNS & Neurological Disorders - Drug Targets Effect of Cholinergic Stimulation in Early Alzheimers Disease - Functional Imaging During a Recognition Memory Task
Current Alzheimer Research The Phosphodiesterase III Inhibitor Cilostazol Ameliorates Ethanolinduced Endothelial Dysfunction
Current Neurovascular Research Clinical Importance of Calcium-Sensing Receptor Gene Polymorphism Arg990Gly in the Age of Calcimimetic Therapy
Current Pharmacogenomics Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
Clinical Cancer Drugs Biomedical Devices for Pathogen Detection Using Microfluidic Chips
Current Proteomics Donepezil: An Important Prototype to the Design of New Drug Candidates for Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Editorial (Thematic Issue: The Multidomain Mobility Lab in Older Persons: From Bench to Bedside)
Current Pharmaceutical Design Editorial [ Hot Topic:Endocannabinoid-Binding Receptors: Old Friends and New Comers (Guest Editor: Mauro Maccarrone)]
Current Medicinal Chemistry The Many Faces of Tourette Syndrome
Current Drug Therapy Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
Current Pharmaceutical Design PDE-5 Inhibitors: Clinical Points
Current Drug Targets Compatible Solute Engineering in Plants for Abiotic Stress Tolerance - Role of Glycine Betaine
Current Genomics